Drugs / Human diploid cell rabies vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03971370 | Sep 2017 → Sep 2018 | — | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human diploid cell rabies vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03971370 ↗ |
| Known as | HDCV | “human diploid cell (HDC) rabies vaccine (HDCV) have been approved” NCT03971370 ↗ |
| Modality | Vaccine | “human diploid cell rabies vaccine” NCT03971370 ↗ |